132 related articles for article (PubMed ID: 2116231)
1. Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide.
Kerr DE; Senter PD; Burnett WV; Hirschberg DL; Hellström I; Hellström KE
Cancer Immunol Immunother; 1990; 31(4):202-6. PubMed ID: 2116231
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs of doxorubicin and melphalan and their activation by a monoclonal antibody-penicillin-G amidase conjugate.
Vrudhula VM; Senter PD; Fischer KJ; Wallace PM
J Med Chem; 1993 Apr; 36(7):919-23. PubMed ID: 8464046
[TBL] [Abstract][Full Text] [Related]
3. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug.
Lu JY; Lowe DA; Kennedy MD; Low PS
J Drug Target; 1999; 7(1):43-53. PubMed ID: 10614814
[TBL] [Abstract][Full Text] [Related]
4. N-(4'-hydroxyphenylacetyl)palytoxin: a palytoxin prodrug that can be activated by a monoclonal antibody-penicillin G amidase conjugate.
Bignami GS; Senter PD; Grothaus PG; Fischer KJ; Humphreys T; Wallace PM
Cancer Res; 1992 Oct; 52(20):5759-64. PubMed ID: 1356620
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates.
Svensson HP; Vrudhula VM; Emswiler JE; MacMaster JF; Cosand WL; Senter PD; Wallace PM
Cancer Res; 1995 Jun; 55(11):2357-65. PubMed ID: 7757987
[TBL] [Abstract][Full Text] [Related]
6. Cephalosporin derivatives of doxorubicin as prodrugs for activation by monoclonal antibody-beta-lactamase conjugates.
Vrudhula VM; Svensson HP; Senter PD
J Med Chem; 1995 Apr; 38(8):1380-5. PubMed ID: 7731023
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
Sinkule JA; Rosen ST; Radosevich JA
Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-beta-lactamase conjugates for the activation of a cephalosporin mustard prodrug.
Svensson HP; Kadow JF; Vrudhula VM; Wallace PM; Senter PD
Bioconjug Chem; 1992; 3(2):176-81. PubMed ID: 1515470
[TBL] [Abstract][Full Text] [Related]
9. Increase of doxorubicin sensitivity for folate receptor positive cells when given as the prodrug N-(phenylacetyl) doxorubicin in combination with folate-conjugated PGA.
Zhang Q; Xiang G; Zhang Y; Yang K; Fan W; Lin J; Zeng F; Wu J
J Pharm Sci; 2006 Oct; 95(10):2266-75. PubMed ID: 16883559
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates.
Senter PD; Schreiber GJ; Hirschberg DL; Ashe SA; Hellström KE; Hellström I
Cancer Res; 1989 Nov; 49(21):5789-92. PubMed ID: 2790791
[TBL] [Abstract][Full Text] [Related]
11. Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate.
Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
Int J Cancer; 2001 Feb; 91(4):550-4. PubMed ID: 11251980
[TBL] [Abstract][Full Text] [Related]
12. [Anticancer activity of N-(phenylacetyl) doxorubicin combined with folate-targeted PGA].
Zhang Q; Xiang GY; Long N; Lin JL; Zeng FB
Yao Xue Xue Bao; 2005 Nov; 40(11):1046-50. PubMed ID: 16499093
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate.
Wallace PM; Senter PD
Bioconjug Chem; 1991; 2(5):349-52. PubMed ID: 1790175
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-beta-lactamase conjugates.
Vrudhula VM; Svensson HP; Kennedy KA; Senter PD; Wallace PM
Bioconjug Chem; 1993; 4(5):334-40. PubMed ID: 8274516
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.
Senter PD; Saulnier MG; Schreiber GJ; Hirschberg DL; Brown JP; Hellström I; Hellström KE
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4842-6. PubMed ID: 3387440
[TBL] [Abstract][Full Text] [Related]
16. Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity.
Braslawsky GR; Kadow K; Knipe J; McGoff K; Edson M; Kaneko T; Greenfield RS
Cancer Immunol Immunother; 1991; 33(6):367-74. PubMed ID: 1878890
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo.
Schmidberger H; King L; Lasky LC; Vallera DA
Cancer Res; 1990 Jun; 50(11):3249-56. PubMed ID: 1692258
[TBL] [Abstract][Full Text] [Related]
18. Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates.
Lidický O; Janoušková O; Strohalm J; Alam M; Klener P; Etrych T
Molecules; 2015 Nov; 20(11):19849-64. PubMed ID: 26556320
[TBL] [Abstract][Full Text] [Related]
19. A doxorubicin-CNGRC-peptide conjugate with prodrug properties.
van Hensbergen Y; Broxterman HJ; Elderkamp YW; Lankelma J; Beers JC; Heijn M; Boven E; Hoekman K; Pinedo HM
Biochem Pharmacol; 2002 Mar; 63(5):897-908. PubMed ID: 11911842
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin: monoclonal antibody conjugate for therapy of human cervical carcinoma.
Yeh MY; Roffler SR; Yu MH
Int J Cancer; 1992 May; 51(2):274-82. PubMed ID: 1568795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
